Company ProfilePremium

GenScript

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
GenScript - Healthcare showcase

Year Founded & Workforce

2002

5,573 Employees

Industry

Healthcare

Services

NanobodyGene Editing
G

GenScript Employee Contacts

282 verified contactsNames, job titles, seniority and locations

View Employee Contacts

GenScript Overview

Company Headquarters: New Jersey, US

Founded: 2002

Workforce: ~5,573

Company Working:GenScript is a biotechnology company that provides solutions for life science applications and research. The company offers services in peptide synthesis, genome editing, cell engineering, mutation and library solutions, preclinical drug development, biologics, and manufacturing. The use of GenScript products is advantageous in the life sciences, vaccine research, immunotherapy, COVID-19 treatment, and new drug development. The company also uses its distinct gene synthesis technique in a number of different industries, such as cell therapies, commercial synthetic materials, translational biomedical development, and life science research. It operates in China, Singapore, Japan, the Netherlands, the UK, and the US.

Strategy

GenScript’ s mission is to offer clients high-quality goods and services, provide career and professional development opportunities for our staff, and generate long-term social value. It is focused on creating top-notch biotech platforms for research and development in synthetic biology and healthcare to support life science research, create ground-breaking technologies, deal with environmental problems, and treat serious illnesses for the benefit of humanity. Additionally, it also focuses on mergers and acquisitions which can give them a good rank among the competitors.

Company Snapshot

$273.4M

Revenue

5,573

Employees

2002

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

  • Strong distribution network across the globe
  • Highly invested in research and development activity as well as the production facility
  • Highly skilled workforce
  • Strong track record of project management in the biotechnology & drugs industry
  • Strong global presence in 100 countries
  • High brand equity
  • Successful track record of launching new products

Weaknesses

  • Highly depended on the US market for revenue generation
  • Limited revenue generated from industrial synthetic biology products segment
  • Low market penetration in new markets
  • High dependence on existing supply chain

Opportunities

  • Collaboration with public sector institutions
  • Growing research and development activity
  • Expansion in small and mid-sized business markets
  • Increase in government spending

Threats

  • Change in raw material cost
  • Availability of counterfeit products
  • Fluctuations in foreign exchange rates
  • Technology disruption because of hacks, piracy etc
  • Increasing international competition and downward pressure on margins

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
November 2021Product LaunchGenScript has launched the GenWand Double-Stranded DNA (dsDNA) service for the manufacture of CRISPR knock-in homology-directed repair (HDR) templates in T-cell engineering.
April 2019Product LaunchGenScript Launched a Single-stranded DNA Service for CRISPR-based gene editing. The newly launched service provides researchers with high-quality, pure ssDNA for CRISPR-based gene insertion, with the goal of accelerating the development of gene therapy, cell therapy, and transgenic animal models for cancer research and treatment.

Product Offering

  • GenScript
    • Nanobody
    • Gene Editing

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 273.4 Mn in 2019 to USD 511.1 Mn in 2021.
GenScript — By Business Segment
Series (USD Mn)201920202021
Sales273.4390.9511.1
R&D Expenditure186263.40

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.